Logo

Accelerating Discovery to Clinic

Paul Dabrowski
Tuesday, September 13, 2022
Tweet
Transcript Embed
  • Email
  • Bookmark
  • <<
  • <
  • >
  • >>

Tweet
Facebook
  • Email

Chapters

  • Introduction
  • Why?
  • What stands in the way of accessible engineered biological therapies?
  • Mission-Driven
  • Synthego was founded to revolutionize genome engineering technology
  • Moving CRISPR forward: synthetic single guide RNA
  • CRISPRevolution sgRNA and multi-guide set the standard
  • 1 million guides synthesized power the revolution
  • Helping translate genomics into the clinic
  • 30,000 engineered cell edits discover and validate targets
  • 1,000 publications show path for new medicines
  • Synthego platform capabilities enable rapid R&D
  • Ultimately making engineered biological therapies accessible to all patients
  • Synthego empowers clinical research organizations with GMP CRISPR
  • Operational full stack technology de-risks translational biology rapidly
  • Next-Gen GMP Manufacturing
  • Synthego Enabling the Future of Cell & Gene Therapies with Industrialized CRISPR Platforms

No transcript for this webinar

More InfoRequest info